1. Home
  2. GHC vs PTCT Comparison

GHC vs PTCT Comparison

Compare GHC & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHC
  • PTCT
  • Stock Information
  • Founded
  • GHC 1877
  • PTCT 1998
  • Country
  • GHC United States
  • PTCT United States
  • Employees
  • GHC N/A
  • PTCT N/A
  • Industry
  • GHC Other Consumer Services
  • PTCT Biotechnology: Pharmaceutical Preparations
  • Sector
  • GHC Real Estate
  • PTCT Health Care
  • Exchange
  • GHC Nasdaq
  • PTCT Nasdaq
  • Market Cap
  • GHC 4.0B
  • PTCT 3.7B
  • IPO Year
  • GHC N/A
  • PTCT 2013
  • Fundamental
  • Price
  • GHC $944.00
  • PTCT $48.60
  • Analyst Decision
  • GHC
  • PTCT Buy
  • Analyst Count
  • GHC 0
  • PTCT 13
  • Target Price
  • GHC N/A
  • PTCT $62.31
  • AVG Volume (30 Days)
  • GHC 21.6K
  • PTCT 1.6M
  • Earning Date
  • GHC 04-30-2025
  • PTCT 05-06-2025
  • Dividend Yield
  • GHC 0.75%
  • PTCT N/A
  • EPS Growth
  • GHC 134.95
  • PTCT N/A
  • EPS
  • GHC 141.53
  • PTCT 7.51
  • Revenue
  • GHC $4,804,157,000.00
  • PTCT $1,772,758,000.00
  • Revenue This Year
  • GHC $0.54
  • PTCT $99.06
  • Revenue Next Year
  • GHC $6.39
  • PTCT N/A
  • P/E Ratio
  • GHC $6.74
  • PTCT $6.46
  • Revenue Growth
  • GHC 5.91
  • PTCT 91.12
  • 52 Week Low
  • GHC $683.00
  • PTCT $28.72
  • 52 Week High
  • GHC $1,015.00
  • PTCT $58.38
  • Technical
  • Relative Strength Index (RSI)
  • GHC 50.10
  • PTCT 55.36
  • Support Level
  • GHC $928.95
  • PTCT $44.54
  • Resistance Level
  • GHC $959.96
  • PTCT $49.15
  • Average True Range (ATR)
  • GHC 12.94
  • PTCT 1.65
  • MACD
  • GHC -1.84
  • PTCT 0.46
  • Stochastic Oscillator
  • GHC 41.76
  • PTCT 85.89

About GHC Graham Holdings Company

Graham Holdings Co. is a diversified education and media company made up of subsidiaries. Firm operations include educational services; television broadcasting; online, print, and local news; home health and hospice care; and manufacturing. The Company segments into the following seven reportable segments: Kaplan International, Higher Education, Supplemental Education, Television Broadcasting, Manufacturing, Healthcare, and Automotive. The majority of revenue comes from the Kaplan International segment, which includes higher education, test preparation, language instruction, and professional training. A large portion of company revenue also comes from the television broadcasting segment through advertising.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

Share on Social Networks: